Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

J Vansteenkiste, R Pirker, B Massuti… - Journal of the …, 2002 - academic.oup.com
… alfa, and the difference was not statistically significant, it is possible that patients with higher
hemoglobin concentrations may benefit from an overall improvement in performance status

[HTML][HTML] A retrospective analysis of veristrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in …

TE Stinchcombe, J Roder, AH Peterman… - Journal of Thoracic …, 2013 - Elsevier
… is not significantly correlated with EGFR or KRAS mutation status, and the absence of a …
with certain prognostic characteristics, such as performance status (PS), it maintained a …

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients …

M Peeters, TJ Price, A Cervantes… - Journal of clinical …, 2010 - ascopubs.org
… Patients with mCRC, one prior chemotherapy regimen for mCRC, Eastern Cooperative
Oncology Group performance status 0 to 2, and available tumor tissue for biomarker testing were …

Randomized phase II evaluation of carboplatin and CHIP in advanced transitional cell carcinoma of the urothelium

DL Trump, P Elson, S Madajewicz, SH Dickman… - The Journal of …, 1990 - Elsevier
Randomization. To balance potential risk factors between the 2 treatments patients were
randomized … measurable versus evaluable disease, and performance status 0 or 1 versus 2 or 3…

[HTML][HTML] A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients …

SH Park, DH Lim, TS Sohn, J Lee, DY Zang, ST Kim… - Annals of …, 2021 - Elsevier
… Eastern Cooperative Oncology Group (ECOG) performance status scores range from 0 to
5, with higher scores indicating greater disability. A score of 0 indicates no symptoms, and 1 …

… concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase …

AV Gaast, P Van Hagen, M Hulshof, D Richel… - Journal of Clinical …, 2010 - ascopubs.org
… results of a phase II study we initiated a phase III study … included performance status, histology,
lymph node status. … age 60 years (36-79), median WHO performance status 0 (0-1), adeno/…

SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective …

GA Van Hazel, V Heinemann, NK Sharma… - Journal of Clinical …, 2016 - ascopubs.org
… ), have a WHO performance status of 0 to 1, and have a life expectancy of ≥ 3 months.
Patient inclusion and exclusion criteria are described in Appendix Table A1 (online only). …

Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results

G Mantovani, A Macciò, C Madeddu, G Gramignano… - Nutrition, 2008 - Elsevier
… Carnitine may be considered a very intriguing drug; in the present study it was found to be
effective in improving fatigue and performance status. Indeed, in one of our recently published …

… factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the …

P Wimberger, N Lehmann, R Kimmig, A Burges… - Gynecologic …, 2007 - Elsevier
… a performance status according to Eastern Cooperative Oncology Group performance status
(ECOG) of 0–2 were enrolled in this multi-center prospective randomized phase III study in …

One versus three fractions of stereotactic body radiation therapy for peripheral stage I to II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial

AK Singh, JA Gomez-Suescun, KL Stephans… - International Journal of …, 2019 - Elsevier
… This randomized phase 2 study demonstrated that 30 Gy in 1 fraction was equivalent to 60
… aged 18 years or older with a Zubrod performance status score of 0 to 2, deemed medically …